Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gleason

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Addictive Behaviors|January 1, 1989
The television, school and family smoking prevention/cessation project. IV. Controlling for program success expectancies across experimental and control conditionsS Sussman, C W Dent, B R Brannon, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1992
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjectsR H Barbhaiya, S T Forgue, C R Gleason, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1992
Non-modulation as an intermediate phenotype in essential hypertensionG H Williams, R G Dluhy, R P Lifton, et al.
Optics Express|March 29, 2012
Detailed validation of the bidirectional effect in various Case I and Case II watersArthur C R Gleason, Kenneth J Voss, Howard R Gordon, et al.
The AAPS Journal|May 1, 2015
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein AssayYan G Ni, Xiling Yuan, John A Newitt, et al.
Preventive Medicine|September 1, 1988
The television school and family smoking prevention and cessation project. 1. Theoretical basis and program developmentB R Flay, B R Brannon, C A Johnson, et al.
The Journal of Clinical Investigation|March 20, 2001
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine modelM A Hofmann, E Lalla, Y Lu, et al.
Immunity|September 5, 2024
Inhibitory co-receptor Lag3 supports Foxp3<sup>+</sup> regulatory T cell function by restraining Myc-dependent metabolic programmingDongkyun Kim, Giha Kim, Rongzhen Yu, et al.
Cancer Cell|July 9, 2021
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myelomaOliver Van Oekelen, Charles R Gleason, Sarita Agte, et al.
Journal of Visualized Experiments : Jove|May 5, 2025
Measuring the Structure, Composition, and Change of Underwater Environments with Large-area ImagingNicole E Pedersen, Vid Petrovic, Hugh Runyan, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Addictive Behaviors|January 1, 1989
The television, school and family smoking prevention/cessation project. IV. Controlling for program success expectancies across experimental and control conditionsS Sussman, C W Dent, B R Brannon, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1992
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjectsR H Barbhaiya, S T Forgue, C R Gleason, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1992
Non-modulation as an intermediate phenotype in essential hypertensionG H Williams, R G Dluhy, R P Lifton, et al.
Optics Express|March 29, 2012
Detailed validation of the bidirectional effect in various Case I and Case II watersArthur C R Gleason, Kenneth J Voss, Howard R Gordon, et al.
The AAPS Journal|May 1, 2015
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein AssayYan G Ni, Xiling Yuan, John A Newitt, et al.
Preventive Medicine|September 1, 1988
The television school and family smoking prevention and cessation project. 1. Theoretical basis and program developmentB R Flay, B R Brannon, C A Johnson, et al.
The Journal of Clinical Investigation|March 20, 2001
Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine modelM A Hofmann, E Lalla, Y Lu, et al.
Immunity|September 5, 2024
Inhibitory co-receptor Lag3 supports Foxp3<sup>+</sup> regulatory T cell function by restraining Myc-dependent metabolic programmingDongkyun Kim, Giha Kim, Rongzhen Yu, et al.
Cancer Cell|July 9, 2021
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myelomaOliver Van Oekelen, Charles R Gleason, Sarita Agte, et al.
Journal of Visualized Experiments : Jove|May 5, 2025
Measuring the Structure, Composition, and Change of Underwater Environments with Large-area ImagingNicole E Pedersen, Vid Petrovic, Hugh Runyan, et al.
Pageof 18